tiprankstipranks
Trending News
More News >
Arch Biopartners (TSE:ARCH)
:ARCH
Canadian Market

Arch Biopartners (ARCH) Financial Statements

Compare
40 Followers

Arch Biopartners Financial Overview

Arch Biopartners's market cap is currently C$83.96M. The company's EPS TTM is C$-0.004; its P/E ratio is -34.60; Arch Biopartners is scheduled to report earnings on August 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 2.12MC$ 1.98MC$ 964.68KC$ 3.89MC$ 67.89K
Gross ProfitC$ -1.66MC$ -129.00KC$ -503.00KC$ -150.00KC$ -2.12M
Operating IncomeC$ -3.95MC$ -3.35MC$ -1.39MC$ -1.17MC$ -4.63M
EBITDAC$ -3.53MC$ -336.00KC$ -101.00KC$ -77.02KC$ -4.45M
Net IncomeC$ -3.92MC$ -3.33MC$ -1.41MC$ -1.17MC$ -4.63M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.97KC$ 831.27KC$ 506.35KC$ 448.24KC$ 653.68K
Total AssetsC$ 935.62KC$ 1.17MC$ 621.64KC$ 2.67MC$ 741.30K
Total DebtC$ 2.77MC$ 5.02MC$ 4.41MC$ 5.16MC$ 3.39M
Net DebtC$ 2.77MC$ 4.18MC$ 3.91MC$ 4.72MC$ 2.74M
Total LiabilitiesC$ 5.28MC$ 6.68MC$ 5.09MC$ 6.55MC$ 4.61M
Stockholders' EquityC$ -4.35MC$ -5.51MC$ -4.47MC$ -3.88MC$ -3.87M
Cash Flow
Free Cash FlowC$ -2.33MC$ -234.08KC$ -1.08MC$ -2.98MC$ -1.90M
Operating Cash FlowC$ -2.33MC$ -234.07KC$ -1.08MC$ -2.98MC$ -1.90M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 1.50MC$ 559.00KC$ -421.37KC$ 2.78MC$ 2.16M
Currency in CAD

Arch Biopartners Earnings and Revenue History

Arch Biopartners Debt to Assets

Arch Biopartners Cash Flow

Arch Biopartners Forecast EPS vs Actual EPS